Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (61-70 of 401) with videos related to

Pageof 41
Sort By:
Journal of Clinical Medicine|July 8, 2020
New Antithrombotic Drugs in Acute Coronary SyndromeBastiaan Zwart, William A E Parker, Robert F Storey
Circulation|May 23, 2018
Response by Angiolillo et al to Letter Regarding Article, "International Expert Consensus Document on Switching Platelet P2Y<sub>12</sub> Receptor Inhibiting Therapies"Dominick J Angiolillo, Matthew J Price, Robert F Storey
The British Journal of Cardiology|September 9, 2024
Drug therapies for stroke preventionNimisha Shaji, Robert F Storey, William A E Parker
Heart (British Cardiac Society)|March 26, 2018
Dual antiplatelet therapy in the 'real world'Eunice N C Onwordi, William Ae Parker, Robert F Storey
Reviews in Cardiovascular Medicine|July 14, 2021
Ticagrelor: clinical development and future potentialNicholas C Sanderson, William A E Parker, Robert F Storey
Biomarkers in Medicine|February 16, 2011
Ticagrelor: from concept to clinical evaluationJames A Shand, Ian B A Menown, Robert F Storey
Thrombosis and Haemostasis|March 6, 2019
Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?Wael Sumaya, Tobias Geisler, Steen D Kristensen, et al.
Journal of Cardiovascular Development and Disease|March 27, 2026
Single-Site Experience in the ONSET-OFFSET Study Demonstrates Pharmacodynamic and Pharmacokinetic Advantages of Ticagrelor over Clopidogrel in Patients with Chronic Coronary SyndromesHeather M Judge, William A E Parker, Robert F Storey
International Journal of Clinical Pharmacology and Therapeutics|February 1, 2017
Population pharmacokinetics of ticagrelor and AR-C124910XX in patients with prior myocardial infarction
Daniel Röshammar, Martin Bergstrand, Tomas Andersson, et al.
Current Cardiology Reports|April 13, 2016
Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS GuidelinesMarco Roffi, Baris Gencer, Robert F Storey, et al.
Pageof 41

Showing results (61-70 of 401) with videos related to

Sort By:
Pageof 41
Journal of Clinical Medicine|July 8, 2020
New Antithrombotic Drugs in Acute Coronary SyndromeBastiaan Zwart, William A E Parker, Robert F Storey
Circulation|May 23, 2018
Response by Angiolillo et al to Letter Regarding Article, "International Expert Consensus Document on Switching Platelet P2Y<sub>12</sub> Receptor Inhibiting Therapies"Dominick J Angiolillo, Matthew J Price, Robert F Storey
The British Journal of Cardiology|September 9, 2024
Drug therapies for stroke preventionNimisha Shaji, Robert F Storey, William A E Parker
Heart (British Cardiac Society)|March 26, 2018
Dual antiplatelet therapy in the 'real world'Eunice N C Onwordi, William Ae Parker, Robert F Storey
Reviews in Cardiovascular Medicine|July 14, 2021
Ticagrelor: clinical development and future potentialNicholas C Sanderson, William A E Parker, Robert F Storey
Biomarkers in Medicine|February 16, 2011
Ticagrelor: from concept to clinical evaluationJames A Shand, Ian B A Menown, Robert F Storey
Thrombosis and Haemostasis|March 6, 2019
Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?Wael Sumaya, Tobias Geisler, Steen D Kristensen, et al.
Journal of Cardiovascular Development and Disease|March 27, 2026
Single-Site Experience in the ONSET-OFFSET Study Demonstrates Pharmacodynamic and Pharmacokinetic Advantages of Ticagrelor over Clopidogrel in Patients with Chronic Coronary SyndromesHeather M Judge, William A E Parker, Robert F Storey
International Journal of Clinical Pharmacology and Therapeutics|February 1, 2017
Population pharmacokinetics of ticagrelor and AR-C124910XX in patients with prior myocardial infarction
Daniel Röshammar, Martin Bergstrand, Tomas Andersson, et al.
Current Cardiology Reports|April 13, 2016
Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS GuidelinesMarco Roffi, Baris Gencer, Robert F Storey, et al.
Pageof 41